6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine

C80H102Br2N14O10S4 — CID 159384919

IUPAC6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine
SMILESCC1(C)CN(c2cc(Br)cc3cccn23)CCN1S(C)(=O)=O.CC1(C)CN(c2cc(Br)cn3cccc23)CCN1S(C)(=O)=O.Cc1cc(C2CCN(C(=O)O)CC2)n2cccc2c1.Cc1cc(N2CCC(c3ccc(NS(C)(=O)=O)cc3)CC2)n2cccc2c1.Cc1cc(N2CCN(S(C)(=O)=O)CC2)n2cccc2c1
InChIInChI=1S/C21H25N3O2S.2C15H20BrN3O2S.C15H18N2O2.C14H19N3O2S/c1-16-14-20-4-3-11-24(20)21(15-16)23-12-9-18(10-13-23)17-5-7-19(8-6-17)22-27(2,25)26;1-15(2)11-18(7-8-19(15)22(3,20)21)14-9-12(16)10-17-6-4-5-13(14)17;1-15(2)11-17(7-8-19(15)22(3,20)21)14-10-12(16)9-13-5-4-6-18(13)14;1-11-9-13-3-2-6-17(13)14(10-11)12-4-7-16(8-5-12)15(18)19;1-12-10-13-4-3-5-17(13)14(11-12)15-6-8-16(9-7-15)20(2,18)19/h3-8,11,14-15,18,22H,9-10,12-13H2,1-2H3;2*4-6,9-10H,7-8,11H2,1-3H3;2-3,6,9-10,12H,4-5,7-8H2,1H3,(H,18,19);3-5,10-11H,6-9H2,1-2H3
InChIKeyLLJINOZSJACUQQ-UHFFFAOYSA-N
MW1707.86 g/mol
LogP13.56
Rot. Bonds11

About 6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine

6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine (PubChem CID 159384919) has the molecular formula C80H102Br2N14O10S4 and a molecular weight of 1707.86 g/mol. Its IUPAC name is 6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine.

Molecular Properties

Compound Name6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine
PubChem CID159384919
Molecular FormulaC80H102Br2N14O10S4
Molecular Weight1707.86 g/mol
Exact Mass1704.52
IUPAC Name6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine
SMILESCC1(C)CN(c2cc(Br)cc3cccn23)CCN1S(C)(=O)=O.CC1(C)CN(c2cc(Br)cn3cccc23)CCN1S(C)(=O)=O.Cc1cc(C2CCN(C(=O)O)CC2)n2cccc2c1.Cc1cc(N2CCC(c3ccc(NS(C)(=O)=O)cc3)CC2)n2cccc2c1.Cc1cc(N2CCN(S(C)(=O)=O)CC2)n2cccc2c1
InChIInChI=1S/C21H25N3O2S.2C15H20BrN3O2S.C15H18N2O2.C14H19N3O2S/c1-16-14-20-4-3-11-24(20)21(15-16)23-12-9-18(10-13-23)17-5-7-19(8-6-17)22-27(2,25)26;1-15(2)11-18(7-8-19(15)22(3,20)21)14-9-12(16)10-17-6-4-5-13(14)17;1-15(2)11-17(7-8-19(15)22(3,20)21)14-10-12(16)9-13-5-4-6-18(13)14;1-11-9-13-3-2-6-17(13)14(10-11)12-4-7-16(8-5-12)15(18)19;1-12-10-13-4-3-5-17(13)14(11-12)15-6-8-16(9-7-15)20(2,18)19/h3-8,11,14-15,18,22H,9-10,12-13H2,1-2H3;2*4-6,9-10H,7-8,11H2,1-3H3;2-3,6,9-10,12H,4-5,7-8H2,1H3,(H,18,19);3-5,10-11H,6-9H2,1-2H3
InChIKeyLLJINOZSJACUQQ-UHFFFAOYSA-N
XLogP13.56
TPSA233.86 Ų
H-Bond Donors2
H-Bond Acceptors18
Rotatable Bonds11
Heavy Atoms110
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001707.86
LogP ≤ 513.56
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1018

Analyze 6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

6-bromo-4-ethylpyridin-3-amine;tert-butyl 4-(5-amino-4-ethyl-2-pyridinyl)piperidine-1-carboxylate;tert-butyl 4-[4-ethyl-5-[(1-methylimidazo[4,5-c]pyridin-6-yl)amino]-2-pyridinyl]piperidine-1-carboxylate;tert-butyl 4-[4-ethyl-5-[methyl-(1-methylimidazo[4,5-c]pyridin-6-yl)amino]-2-pyridinyl]piperidine-1-carboxylate;tert-butyl 4-iodopiperidine-1-carboxylate;N-[4-ethyl-6-(1-methylsulfonylpiperidin-4-yl)-3-pyridinyl]-N,1-dimethylimidazo[4,5-c]pyridin-6-amine;N-(4-ethyl-6-piperidin-4-yl-3-pyridinyl)-N,1-dimethylimidazo[4,5-c]pyridin-6-amine
CID 160657051

Frequently Asked Questions

What is the IUPAC name of 6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine?
The IUPAC name of 6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine (CID 159384919) is 6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine.
What is the SMILES notation for 6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine?
The canonical SMILES for 6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine is CC1(C)CN(c2cc(Br)cc3cccn23)CCN1S(C)(=O)=O.CC1(C)CN(c2cc(Br)cn3cccc23)CCN1S(C)(=O)=O.Cc1cc(C2CCN(C(=O)O)CC2)n2cccc2c1.Cc1cc(N2CCC(c3ccc(NS(C)(=O)=O)cc3)CC2)n2cccc2c1.Cc1cc(N2CCN(S(C)(=O)=O)CC2)n2cccc2c1.
What is the InChIKey of 6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine?
The InChIKey is LLJINOZSJACUQQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H25N3O2S.2C15H20BrN3O2S.C15H18N2O2.C14H19N3O2S/c1-16-14-20-4-3-11-24(20)21(15-16)23-12-9-18(10-13-23)17-5-7-19(8-6-17)22-27(2,25)26;1-15(2)11-18(7-8-19(15)22(3,20)21)14-9-12(16)10-17-6-4-5-13(14)17;1-15(2)11-17(7-8-19(15)22(3,20)21)14-10-12(16)9-13-5-4-6-18(13)14;1-11-9-13-3-2-6-17(13)14(10-11)12-4-7-16(8-5-12)15(18)19;1-12-10-13-4-3-5-17(13)14(11-12)15-6-8-16(9-7-15)20(2,18)19/h3-8,11,14-15,18,22H,9-10,12-13H2,1-2H3;2*4-6,9-10H,7-8,11H2,1-3H3;2-3,6,9-10,12H,4-5,7-8H2,1H3,(H,18,19);3-5,10-11H,6-9H2,1-2H3.
What are the key properties of 6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine?
6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine has a molecular weight of 1707.86 g/mol, XLogP of 13.56, 11 rotatable bonds, 2 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 6-bromo-8-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;7-bromo-5-(3,3-dimethyl-4-methylsulfonylpiperazin-1-yl)indolizine;4-(7-methylindolizin-5-yl)piperidine-1-carboxylic acid;N-[4-[1-(7-methylindolizin-5-yl)piperidin-4-yl]phenyl]methanesulfonamide;7-methyl-5-(4-methylsulfonylpiperazin-1-yl)indolizine is sourced from PubChem (CID 159384919), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).